ESR1 and breast carcinoma: Previous studies have already been reported that ER promotes transcription of genes which cause breast cancer and its metastasis [12], and the AR inhibitor Enzalutamide reduced ERα genomic binding by 50% [21], but how AR regulates ER transcriptome in ER+ breast cancer cells and whether it induces metastasis is not known.